Survey of Adherence to Immunosuppression and Other Medications in Kidney Transplant Patients

Sponsor

State University of New York - Downstate Medical Center (Other)

Overall Status

Completed

CT.gov ID

NCT00433134

Collaborator

(none)

100

Enrollment

Location

Duration (Months)

8.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Goal:

To define the causes and issues associated with nonadherence in our population

Hypothesis:

There is a difference in the rates and patterns of adherence to transplant medications versus other medications also taken by transplant patients

Methods:

A standardized interviewer-administered confidential survey exploring levels of adherence to transplant medications and other medications as well questionnaires on a variety of cognitive and other factors known to be associated with adherence.
A brief review of demographics and pertinent laboratory information at the same encounter

Condition or Disease	Intervention/Treatment	Phase
Kidney Transplantation Treatment Refusal Patient Compliance	Behavioral: Adherence

Detailed Description

Objectives:

To determine the prevalence of nonadherence in our population
To assess possible causes of nonadherence and correlate those causes with demographic information and clinical findings
To assess for differences between adherence with immunosuppressive regime versus adherence with other medications (for hypertension, diabetes, hypercholesterolemia)

Methods:

A standardized interviewer-administered confidential survey exploring levels of adherence to transplant medications and other medications as well questionnaires on a variety of cognitive and other factors known to be associated with adherence
A brief review of demographics and pertinent laboratory information at the same encounter

Study Design

Study Type:

Observational

Anticipated Enrollment :

100 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Survey Investigation of Adherence to Immunosuppression and Other Medications Among Kidney Transplant Recipients at SUNY Downstate

Study Start Date :

Jun 1, 2006

Actual Primary Completion Date :

Jun 1, 2007

Actual Study Completion Date :

Jun 1, 2007

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

All renal transplant recipients with a working transplant who are currently attending the transplant clinic and who have been transplanted 6 months to 4.5 years ago are eligible. Patients are recruited at random from the transplant clinic waiting area

Exclusion Criteria:

Less than 6 months post-transplant
More than 4.5 years post transplant

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	SUNY Downstate Medical Center	Brooklyn	New York	United States	11203

Sponsors and Collaborators

State University of New York - Downstate Medical Center

Investigators

Principal Investigator: Mariana Markell, MD, State University of New York - Downstate Medical Center
Principal Investigator: Sima Terebelo, MPH, RPA-C, State University of New York - Downstate Medical Center